An immunomodulatory encapsulation system to deliver human iPSC-derived dopaminergic neuron progenitors for Parkinson’s disease treatment

1 day ago 3
Biomater. Sci., 2025, Accepted Manuscript
DOI: 10.1039/D4BM01566E, Paper
Open Access Open Access
Creative Commons Licence&nbsp This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
Emily Atkinson, Holly N Gregory, Lara N Carter, Rachael E Evans, Victoria H Roberton, Rachael Dickman, James Phillips
Parkinson’s disease is a neurodegenerative condition associated with the progressive loss of dopaminergic neurons. This leads to neurological impairments with heightening severity and is globally increasing in prevalence due to...
The content of this RSS Feed (c) The Royal Society of Chemistry
Read Entire Article